Publicaciones en las que colabora con SANTIAGO TORRADO DURÁN (15)

2019

  1. Submicellar liquid chromatography with fluorescence detection improves the analysis of naproxen in plasma and brain tissue

    Journal of Separation Science, Vol. 42, Núm. 9, pp. 1702-1709

2018

  1. Efficacy, biodistribution, and nephrotoxicity of experimental amphotericin B-deoxycholate formulations for pulmonary aspergillosis

    Antimicrobial Agents and Chemotherapy, Vol. 62, Núm. 7

2017

  1. Improvement of the surface hydrophilic properties of naproxen particles with addition of hydroxypropylmethyl cellulose and sodium dodecyl sulphate: In vitro and in vivo studies

    International Journal of Pharmaceutics, Vol. 529, Núm. 1-2, pp. 381-390

2016

  1. New Multi-Particle Systems for Colon-Targeted Meloxicam

    Journal of Applied Pharmacy, Vol. 8, Núm. 3, pp. 1-3

2015

  1. Efficacy and toxicity evaluation of new amphotericin B micelle systems for brain fungal infections

    International Journal of Pharmaceutics, Vol. 494, Núm. 1, pp. 17-22

2014

  1. Enhanced bioavailability and anthelmintic efficacy of mebendazole in redispersible microparticles with low-substituted hydroxypropylcellulose

    Drug Design, Development and Therapy, Vol. 8, pp. 1467-1479

2011

  1. Changed crystallinity of mebendazole solid dispersion: Improved anthelmintic activity

    International Journal of Pharmaceutics, Vol. 403, Núm. 1-2, pp. 23-28

2006

  1. Microcapsules formulated in the enteric coating copolymer Eudragit L100 as delivery systems for oral vaccination against infections by gastrointestinal nematode parasites

    Journal of Drug Targeting, Vol. 14, Núm. 8, pp. 567-575

2005

  1. Influence of the vehicle on the properties and efficacy of microparticles containing amphotericin B

    Journal of Drug Targeting, Vol. 13, Núm. 4, pp. 225-233

2004

  1. Amphotericin B molecular organization as an essential factor to improve activity/toxicity ratio in the treatment of visceral leishmaniasis

    Journal of Drug Targeting, Vol. 12, Núm. 7, pp. 453-460

  2. Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres

    Antimicrobial Agents and Chemotherapy, Vol. 48, Núm. 9, pp. 3246-3252

1998

  1. A selective and simple RP-HPLC assay to quantify albendazole metabolites in plasma

    Journal of Liquid Chromatography and Related Technologies, Vol. 21, Núm. 15, pp. 2327-2340

  2. Methimazole-mediated enhancement of albendazole oral bioavailability and anthelmintic effects against parenteral stages of Trichinella spiralis in mice: The influence of the dose-regime

    Veterinary Parasitology, Vol. 75, Núm. 2-3, pp. 209-219

1997

  1. A novel formulation of albendazole solution: Oral bioavailability and efficacy evaluation

    International Journal of Pharmaceutics, Vol. 156, Núm. 2, pp. 181-187

  2. Improvement of albendazole efficacy against enteral, but not against parenteral stages of trichinella spiralis by preparing solid dispersions in polyvinylpyrrolidone

    Chemotherapy, Vol. 43, Núm. 6, pp. 430-435